"
Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.
CAS ID |
N/A |
||
INCHI KEY |
DRLFMBDRBRZALE-UHFFFAOYSA-N |
||
MOLECULAR WEIGHT |
232.28 |
||
MOLECULAR FORMULA |
C13H16N2O2 |
||
MOLECULAR MASS |
232.283 |
||
BIOLOGICAL SOURCE |
Juglans regia |
||
DATA SOURCE |
U.S. Department of Agriculture, Agricultural Research Service. 1992-2016. Dr. Duke's Phytochemical and Ethnobotanical Databases. Home Page, http://phytochem.nal.usda.gov/ http://dx.doi.org/10.15482/USDA.ADC/1239279 | ||
CHEMICAL CLASS OF COMPOUND |
Indoles and derivatives |
||
NLRP3 DOCKING SCORE(Kcal/mol) |
-4.511 |
||
CANONICAL SMILES COc1ccc2[nH]cc(CCNC(C)=O)c2c1
|
|||
BIOACTIVITY REPORTED FOR NEURODEGENERATIVE DISEASES
Yes
|
|||
SYNONYMS |
Melatonin, 73-31-4, Melatonine, N-Acetyl-5-methoxytryptamine, Circadin, N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide, 5-Methoxy-N-acetyltryptamine, N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide, Melatol, Melovine, 8041-44-9, Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-, N-[2-(5-methoxyindol-3-yl)ethyl]acetamide, N-acetyl-5-methoxy-tryptamine, CCRIS 3472, NSC 113928, Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-, UNII-JL5DK93RCL, JL5DK93RCL, Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-, N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide, EINECS 200-797-7, MFCD00005655, NSC-56423, 5-methoxy n-acetyl-tryptamine, NSC-113928, BRN 0205542, DTXSID1022421, CHEBI:16796, HSDB 7509, BCI-049, CHEMBL45, NSC113928, J5.258B, DTXCID002421, Melatonex, Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-, Melatonin (JAN), 5-22-12-00042 (Beilstein Handbook Reference), NSC56423, CAS-73-31-4, NCGC00015680-11, MELATONIN [JAN], MELATONIN (MART.), MELATONIN [MART.], MELATONIN (USP-RS), MELATONIN [USP-RS], Melatonina, Melapure, Posidorm, Primex, WLN: T56 BMJ D2MV1 GO1, [3H]melatonin, Melatonina (TN), [3H]-melatonin, ML1, SMR000326666, N-(2-(5-methoxyindol-3-yl)ethyl)-Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-Acetamide, N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide, SR-01000075559, somease, [3H]MLT, Melatobel, Melaxen, Melatonine?, 3-(n-acetyl-2-aminoethyl)-5-methoxyindole, Guna-dermo, Amerix Melatonin, Safrel Melatonin, Melatonin Phenolic, Melatobel (TN), TNP00300, Melatonin1527, Prestwick_312, N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide, Therapeutic Melatonin, Spectrum_000185, MELATONIN [DSC], Guna-dermo (Salt/Mix), MELATONIN [MI], MELATONIN [HSDB], Prestwick0_000458, Prestwick1_000458, Prestwick2_000458, Prestwick3_000458, Spectrum2_001344, Spectrum3_001393, Spectrum4_000066, Spectrum5_001745, Lopac-M-5250, MELATONIN [VANDF], M1105, ChemDiv2_003916, M 5250, M-1200, M-1250, Melatonin, >=99.5%, MELATONIN [WHO-DD], Lopac0_000787, Oprea1_104553, Oprea1_814234, SCHEMBL19018, BSPBio_000536, BSPBio_003006, GTPL224, KBioGR_000591, KBioSS_000665, MELATONIN [EMA EPAR], Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}, MLS000859594, MLS001055382, MLS001240204, BIDD:ER0618, DivK1c_000353, SPECTRUM1500690, SPBio_001527, SPBio_002475, Melatonin (synth.) ultra-pure, MELATONIN [GREEN BOOK], BDBM9019, BPBio1_000590, GTPL1357, Melatonin Rapid Release Gelcaps, Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}, HMS501B15, KBio1_000353, KBio2_000665, KBio2_003233, KBio2_005801, KBio3_002226, Melatonin 1.0 mg/ml in Methanol, NINDS_000353, GLXC-25215, HMS1380B22, HMS1569K18, HMS1921E04, HMS2089F09, HMS2096K18, HMS2233D23, HMS3262M16, HMS3370J20, HMS3413P14, HMS3654A22, HMS3677P14, HMS3713K18, HMS3884M05, Melatonin (synth.) standard-grade, BCP28154, HY-B0075, Tox21_110195, Tox21_201527, Tox21_302926, Tox21_500787, CCG-38837, HSCI1_000400, Melatonin, powder, >=98% (TLC), STK386880, Melatonin Rapid Release Gelcaps 5 mg, AKOS000276269, Tox21_110195_1, CS-1769, DB01065, KS-1454, LP00787, SDCCGMLS-0065812.P001, SDCCGMLS-0065812.P002, SDCCGSBI-0050765.P003, IDI1_000353, IDI1_002631, SMP2_000309, N-acetyl-5-methoxy-tryptamine Melatonine, NCGC00015680-01, NCGC00015680-02, NCGC00015680-03, NCGC00015680-04, NCGC00015680-05, NCGC00015680-06, NCGC00015680-07, NCGC00015680-08, NCGC00015680-09, NCGC00015680-10, NCGC00015680-12, NCGC00015680-13, NCGC00015680-14, NCGC00015680-15, NCGC00015680-16, NCGC00015680-18, NCGC00015680-34, NCGC00015680-35, NCGC00090727-01, NCGC00090727-02, NCGC00090727-03, NCGC00090727-04, NCGC00090727-05, NCGC00090727-06, NCGC00090727-07, NCGC00090727-08, NCGC00090727-09, NCGC00256404-01, NCGC00259077-01, NCGC00261472-01, AC-10019, BA164660, NCI60_004378, SY051401, AB00053279, EU-0100787, NS00009598, S1204, SW196607-4, C01598, D08170, M02088, AB00053279-10, AB00053279_12, EN300-6486827, {N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide, L001261, Melatonine , N-Acetyl-5-methoxytryptamine, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-Acetamide, Q180912, SR-01000075559-1, SR-01000075559-6, SR-01000075559-7, SR-01000075559-8, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide, BRD-K97530723-001-07-6, BRD-K97530723-001-11-8, BRD-K97530723-001-19-1, BRD-K97530723-001-20-9, F1929-1777, Melatonin, British Pharmacopoeia (BP) Reference Standard, Z1191880499, 0E2B08C1-B325-45B1-8939-6F9081EFDFA4, Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI), Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI), Melatonin, United States Pharmacopeia (USP) Reference Standard, Melatonin, Pharmaceutical Secondary Standard; Certified Reference Material |
||